Based on genomic datasets, the expression profiles of candidate genes in CCA cases were analyzed using GEO databases and the increasing levels of feasible tumor markers including HMGB1, SOX9, and YAP1 in patients with CCA. The gene discussed is YAP1; the disease is cholangiocarcinoma.